Olga S. S.
- Country
- Spain
- Department
- Endocrinology
Research Overview
- Myocardial Insulin Resistance in Type 2 Diabetes: Effects of Semaglutide vs Dapagliflozin on Cardiac Function Assessed by 18F‑FDG PET/CT and 99mTc‑Tetrofosmin SPECT
- Evaluation of Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to Insulin Glargine 300 U/mL in Type 2 Diabetes Patients with Renal Impairment
- Insulin resistance in type 2 diabetes: evaluating the pathogenic mechanisms of insulin resistance in the myocardium and the effects of the treatments with GLP-1RA and SGLT2i
Data & Insights
Has run more than one trial at 1 of 11 partner sites.
Specializations
Diabetes Management
This investigator specializes in the management of Type 2 Diabetes Mellitus, with particular emphasis on patients with complex medical conditions.
- Insulin therapy optimization
- Renal complications in diabetes
- Blood glucose control strategies
Their research encompasses innovative approaches to insulin treatment regimens in diabetic patients with kidney impairment.
Endocrine Disorders
The investigator focuses on metabolic disorders and their management, particularly in relation to insulin-dependent conditions.
- Insulin therapy advancement
- Metabolic control optimization
- Treatment adaptation strategies
Their work includes evaluating treatment modifications for patients with complex endocrine conditions.
Renal Medicine
The investigator has developed expertise in managing diabetic complications in patients with renal impairment.
- Diabetes-related kidney disease
- Therapeutic adjustments for renal patients
- Complex patient care
Their research interests include optimizing treatment approaches for patients with concurrent diabetes and kidney conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.